<DOC>
	<DOCNO>NCT02080312</DOCNO>
	<brief_summary>This pilot study patient clinical symptom Ménière 's disease use injection dilute magnetic resonance imaging ( MRI ) contrast agent ear evaluate inner ear structure . The goal reproduce image finding describe non-United States ( US ) institution , improve image quality decrease scan time evaluate dynamic contrast movement inner ear structure .</brief_summary>
	<brief_title>Magnetic Resonance Imaging Evaluation Inner Ear Pathology Using Intra-Tympanic Contrast Agent</brief_title>
	<detailed_description>Participants schedule study session 2 consecutive day include consent , baseline audiometric evaluation , intra-tympanic contrast administration , serial MR imaging , follow-up audiometry evaluation inject ear . Participants 59 year old medical condition blood test check kidney function ensure safely receive contrast .</detailed_description>
	<mesh_term>Meniere Disease</mesh_term>
	<criteria>Symptoms clinical exam consistent Ménière 's disease Ability undergo MR exam Interest participating study Ability provide inform consent Children ( age 18 ) , Contraindication MR imaging ( see attach UCSD MR Screening Form ) Claustrophobia preclude MR exam without sedation Contraindication receive intravenous gadoliniumbased contrast agent ( see attach UCSD Contrast Policy ) Patients pregnant breast feeding ( intravenous contrast agent Category C ) Contraindication osmotic challenge ( congestive heart failure , renal failure , hepatic failure )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Meniere 's disease</keyword>
	<keyword>endolymphatic hydrops</keyword>
</DOC>